STANDARD BIOTOOLS INC. 8-K

What Happened
Standard BioTools Inc. announced in a Form 8-K (Item 8.01) that on June 5, 2026 it received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC confirming the company has regained compliance with Nasdaq Listing Rule 5450(a)(1) (the $1.00 minimum bid price requirement). The company had previously received a notice on April 20, 2026 that its common stock (par value $0.001) had closed below $1.00 per share for 30 consecutive business days. Nasdaq has closed the matter.

Key Details

• Date of compliance confirmation: June 5, 2026.
• Prior noncompliance notice received: April 20, 2026.
• Rule involved: Nasdaq Listing Rule 5450(a)(1) — $1.00 minimum bid price requirement.
• Security: Common stock, par value $0.001, listed on The Nasdaq Global Select Market; filing reported under Form 8-K, Item 8.01.

Why It Matters
Regaining compliance means the company now meets Nasdaq's minimum bid price standard and the Nasdaq Listing Qualifications matter is closed, preserving its continued listing on the Nasdaq Global Select Market. For investors, this reduces an immediate regulatory risk related to potential delisting and helps maintain the stock’s market visibility and liquidity. The 8-K contains no other operational or financial updates.